Triple-Negative Breast Cancer: Symptoms, Diagnosis, and Treatment Options

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that does not have estrogen receptors (ER), progesterone receptors (PR), or high levels of the HER2 protein. Because it lacks these common treatment targets, TNBC is treated differently from many other forms of breast cancer. Advances in chemotherapy, immunotherapy, targeted therapies, and personalized treatment approaches have improved outcomes for many people diagnosed with this disease. Treatment is based on the stage of the cancer, tumor characteristics, overall health, and individual treatment goals.

What Is Triple-Negative Breast Cancer?

TNBC accounts for approximately 10–15% of all breast cancers.

It is called "triple-negative" because the cancer cells test negative for:

• Estrogen receptors (ER)
• Progesterone receptors (PR)
• HER2 protein overexpression

Without these receptors, hormone therapy and HER2-targeted medications are generally not effective.

Common Symptoms

Symptoms may include:

• A new breast lump
• Swelling in part or all of the breast
• Changes in breast size or shape
• Skin dimpling or thickening
• Nipple inversion
• Nipple discharge
• Persistent breast pain
• Swollen lymph nodes under the arm or near the collarbone

Any new breast change should be evaluated by a healthcare professional.

Risk Factors

Factors associated with TNBC may include:

• Younger age at diagnosis
• Certain inherited genetic mutations, particularly BRCA1
• Family history of breast or ovarian cancer
• Female sex, although men can also develop breast cancer

Many people diagnosed with TNBC have no known risk factors.

How It Is Diagnosed

Diagnosis typically involves:

• Clinical breast examination
• Mammography
• Breast ultrasound
• Breast MRI in selected cases
• Core needle biopsy
• Laboratory testing of the tumor for ER, PR, and HER2 status

Additional imaging may be recommended to determine the stage of the disease.

Treatment Options

Treatment depends on the stage and characteristics of the cancer.

Possible treatments include:

• Surgery
• Chemotherapy
• Immunotherapy for eligible patients
• Targeted therapy for selected individuals with specific genetic findings
• Radiation therapy
• Participation in clinical trials when appropriate

Many treatment plans involve a combination of these approaches.

Genetic Testing

Some people with TNBC may benefit from genetic counseling and testing.

Testing may identify inherited mutations that can:

• Influence treatment decisions
• Help estimate future cancer risk
• Provide information for family members

A healthcare provider can determine whether testing is appropriate.

Follow-Up Care

After treatment, regular follow-up appointments are important to:

• Monitor recovery
• Detect recurrence
• Manage treatment-related side effects
• Support long-term health

Follow-up schedules vary based on individual circumstances.

Healthy Lifestyle During Recovery

Many healthcare providers encourage:

• Regular physical activity as tolerated
• A balanced diet
• Maintaining a healthy weight
• Avoiding tobacco products
• Limiting alcohol consumption
• Keeping scheduled follow-up visits

These habits support overall health but do not replace medical treatment.

Conclusion

Triple-negative breast cancer is a distinct form of breast cancer that requires specialized treatment because it lacks common hormone and HER2 receptors. Modern treatment may include surgery, chemotherapy, immunotherapy, radiation therapy, and targeted therapies for eligible patients. Early diagnosis, individualized treatment planning, and ongoing follow-up care play important roles in improving outcomes and supporting long-term health.